Related Experiment Video
Updated: May 7, 2026
09:45
Measuring Cardiac Autonomic Nervous System ANS Activity in Children
Published on: April 29, 2013
22.4K
[ESRD in children and adolescents]
J Harambat1, J Hogan, M-Al Macher
1Hôpital Pellegrin-Enfants, CHU Bordeaux, France.
Nephrologie & Therapeutique
|October 15, 2013
Summary
Pediatric End-Stage Renal Disease (ESRD) in France shows stable incidence and prevalence. Renal transplantation offers the best long-term survival outcomes for children with ESRD.
Area of Science:
- Pediatric Nephrology
- Epidemiology of Renal Diseases
- Public Health Indicators
Context:
- End-Stage Renal Disease (ESRD) in children presents unique challenges in diagnosis and management.
- Understanding the epidemiology and treatment outcomes is crucial for improving pediatric kidney care in France.
Purpose:
- To describe the specificity of pediatric ESRD in France.
- To analyze patient outcomes and treatment modalities for children with ESRD.
- To provide data for optimizing care strategies.
Summary:
- In 2011, pediatric ESRD incidence and prevalence in France were stable (8 and 53 pmp). Uropathies, hypodysplasia, glomerulonephritis, and genetic diseases were primary causes.
- Hemodialysis was common, while peritoneal dialysis was reserved for younger children. Preemptive transplantation accounted for 27.7% of new cases.
- Younger children (<4 years) faced higher mortality risks (88% 2-year survival vs. 98% for older children). Renal transplantation significantly extends life expectancy by 20-40 years.
Impact:
- Highlights the critical need for early intervention and improved treatment strategies for pediatric ESRD.
- Emphasizes renal transplantation as the optimal treatment for enhancing long-term survival and quality of life in children.
- Provides essential data for French healthcare policy and resource allocation in pediatric nephrology.
Keywords:
End stage renal diseaseInsuffisance rénale terminalechildrendialysedialysisenfantsrenal transplantationtransplantation rénaleMore Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
16.7K
09:36Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
26.7K
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
414
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414
01:29Drug Dosing: Infants and Children
1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
417
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
343
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
343
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
562
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
982
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982